Myozyme

(Alglucosidase alfa)

Myozyme

Drug updated on 10/23/2023

Dosage FormInjection (intravenous: 5mg/ml)
Drug ClassLysosomal glycogen-specific enzyme
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For use in patients with Pompe disease (GAA deficiency).

Product Monograph / Prescribing Information

Document TitleYearSource
Myozyme (alglucosidase alfa) Prescribing Information.2019Genzyme Corporation Cambridge, MA

Systematic Reviews / Meta-Analyses